Related references
Note: Only part of the references are listed.Population pharmacokinetic and pharmacodynamic analysis of BIIB023, an anti-TNF-like weak inducer of apoptosis (anti-TWEAK) monoclonal antibody
Gerald R. Galluppi et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Soluble Fn14 Is Detected and Elevated in Mouse and Human Kidney Disease
M. Nusrat Sharif et al.
PLOS ONE (2016)
Assessing the Impact of Tissue Target Concentration Data on Uncertainty in In Vivo Target Coverage Predictions
A. Tiwari et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2016)
Role of Fn14 in acute alcoholic steatohepatitis in mice
Gamze Karaca et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2015)
TNF-like weak inducer of apoptosis promotes blood brain barrier disruption and increases neuronal cell death in MRL/lpr mice
Jing Wen et al.
JOURNAL OF AUTOIMMUNITY (2015)
Deficiency of Fibroblast Growth Factor-Inducible 14 (Fn14) Preserves the Filtration Barrier and Ameliorates Lupus Nephritis
Yumin Xia et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
The TWEAK-Fn14 pathway: A potent regulator of skeletal muscle biology in health and disease
Marjan M. Tajrishi et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2014)
TWEAK and the progression of renal disease: clinical translation
Ana B. Sanz et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Quantitative Analysis of Target Coverage and Germinal Center Response by a CXCL13 Neutralizing Antibody in a T-Dependent Mouse Immunization Model
Joanne Brodfuehrer et al.
PHARMACEUTICAL RESEARCH (2014)
TWEAK-Fn14 cytokine-receptor axis: a new player of myocardial remodeling and cardiac failure
Tatyana Novoyatleva et al.
FRONTIERS IN IMMUNOLOGY (2014)
Incorporating Target Shedding Into a Minimal PBPK-TMDD Model for Monoclonal Antibodies
L. Li et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2014)
Fn14 in podocytes and proteinuric kidney disease
Maria Dolores Sanchez-Nino et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
TWEAK/Fn14 axis is a positive regulator of cardiac hypertrophy
Tatyana Novoyatleva et al.
CYTOKINE (2013)
Circulating TNF receptor 2 is associated with the development of chronic kidney disease in non-obese Japanese patients with type 2 diabetes
Yoshio Izumi et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2013)
Fibroblast Growth Factor Inducible (Fn14)-specific Antibodies Concomitantly Display Signaling Pathway-specific Agonistic and Antagonistic Activity
Steffen Salzmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
TWEAK/Fn14 pathway promotes a T helper 2-type chronic colitis with fibrosis in mice
A. Son et al.
MUCOSAL IMMUNOLOGY (2013)
TWEAK/Fn14 axis-targeted therapeutics: moving basic science discoveries to the clinic
Emily Cheng et al.
FRONTIERS IN IMMUNOLOGY (2013)
Tweak/Fn14 and non-canonical NF-kappaB signaling in kidney disease
Jonay Poveda et al.
FRONTIERS IN IMMUNOLOGY (2013)
Measurement of human plasma proteome dynamics with (H2O)-H-2 and liquid chromatography tandem mass spectrometry
John C. Price et al.
ANALYTICAL BIOCHEMISTRY (2012)
Inhibition of the TWEAK/Fn14 pathway attenuates renal disease in nephrotoxic serum nephritis
Yumin Xia et al.
CLINICAL IMMUNOLOGY (2012)
Role of TWEAK in lupus nephritis: A bench-to-bedside review
Jennifer S. Michaelson et al.
JOURNAL OF AUTOIMMUNITY (2012)
Towards a platform PBPK model to characterize the plasma and tissue disposition of monoclonal antibodies in preclinical species and human
Dhaval K. Shah et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2012)
The role of TWEAK/Fn14 in cardiac remodeling
Man-Yi Ren et al.
MOLECULAR BIOLOGY REPORTS (2012)
TWEAK-Fn14 as a mediator of acute kidney injury
Joel M. Weinberg
KIDNEY INTERNATIONAL (2011)
TWEAK, a multifunctional cytokine in kidney injury
Ana Belen Sanz et al.
KIDNEY INTERNATIONAL (2011)
Therapeutic potential of the TWEAK/Fn14 pathway in intractable gastrointestinal cancer
Ryo Yoriki et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2011)
Tumor Necrosis Factor-Like Weak Inducer of Apoptosis Is a Mitogen for Liver Progenitor Cells
Janina E. E. Tirnitz-Parker et al.
HEPATOLOGY (2010)
Soluble and Transmembrane TNF-Like Weak Inducer of Apoptosis Differentially Activate the Classical and Noncanonical NF-κB Pathway
Claudia Roos et al.
JOURNAL OF IMMUNOLOGY (2010)
Therapeutic monoclonal antibody concentration monitoring: free or total?
Bing Kuang et al.
BIOANALYSIS (2010)
TWEAK stimulation of kidney resident cells in the pathogenesis of graft versus host induced lupus nephritis
Alberto Molano et al.
IMMUNOLOGY LETTERS (2009)
Tweak induces proliferation in renal tubular epithelium: a role in uninephrectomy induced renal hyperplasia
Ana B. Sanz et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
No end in site: TWEAK/Fn14 activation and autoimmunity associated end-organ pathologies
Timothy S. Zheng et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
The cytokine TWEAK modulates renal tubulointerstitial inflammation
Ana Belen Sanz et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
The TWEAK - Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting
Jeffrey A. Winkles
NATURE REVIEWS DRUG DISCOVERY (2008)
TWEAK/Fn14 interactions are instrumental in the pathogenesis of nephritis in the chronic graft-versus-host model of systemic lupus erythematosus
Zeguo Zhao et al.
JOURNAL OF IMMUNOLOGY (2007)
TWEAK and the central nervous system
Manuel Yepes
MOLECULAR NEUROBIOLOGY (2007)
Cytokine cooperation in renal tubular cell injury: The role of TWEAK
P. Justo et al.
KIDNEY INTERNATIONAL (2006)
TWEAK binding to the Fn14 cysteine-rich domain depends on charged residues located in both the A1 and D2 modules
Sharron A. N. Brown et al.
BIOCHEMICAL JOURNAL (2006)
Human amyloid-β synthesis and clearance rates as measured in cerebrospinal fluid in vivo
Randall J. Bateman et al.
NATURE MEDICINE (2006)
Population pharmacokinetics of trastuzumab in patients With HER2+ metastatic breast cancer
R Bruno et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2005)
TNF-related weak inducer of apoptosis receptor, a TNF receptor superfamily member, activates NF-κB through TNF receptor-associated factors
SY Han et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
The Fn14 cytoplasmic tall binds tumour-necrosis-factor-receptor-associated factors 1, 2, 3 and 5 and mediates nuclear factor-κB activation
SAN Brown et al.
BIOCHEMICAL JOURNAL (2003)
Fibroblast growth factor-inducible 14 mediates multiple pathways of TWEAK-induced cell death
M Nakayama et al.
JOURNAL OF IMMUNOLOGY (2003)
A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis
SR Wiley et al.
IMMUNITY (2001)
The Fn14 immediate-early response gene is induced during liver regeneration and highly expressed in both human and murine hepatocellular carcinomas
SLY Feng et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Share Paper
